EHA 2020 | R/R DLBCL: impact of allo-HSCT conditioning on patient survival

Nilanjan Ghosh MD, PhD, of Levine Cancer Institute, Charlotte, NC, explores the impact of conditioning prior to allogeneic hematopoietic stem cell transplants (allo-HSCT) on survival for relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).